Skip to main content
Clinical Trials/RPCEC00000304
RPCEC00000304
Not yet recruiting
未知

Efficacy of enhanced recovery protocols implementation in cardiac surgery. Randomized clinical trial - ERACSE

Hermanos Ameijeiras Hospital0 sites84 target enrollmentNovember 20, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Coronary artery disease, valvular and aortic diseases
Sponsor
Hermanos Ameijeiras Hospital
Enrollment
84
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 20, 2019
End Date
April 4, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Obtain Informed consent
  • 2\. Patient without prior cardiac surgery.
  • 3\. Functional classification by NYHA or Canadian society in grade I, II or III.
  • 4\. Cardiac ejection fraction more than 45 %.
  • 5\. Absent of symptomatic arrhythmias.
  • 6\. Alert and without neurological dysfunction.
  • 7\. Urinary output more than 0\.5 ml/Kg body weight, with creatinin level less than 132 mmol/l.
  • 8 Absent of lung congestion sing in the thoracic X\-ray.

Exclusion Criteria

  • 1\. Urgent or emergent cardiac surgery.
  • 2\. Acute myocardial infarction (less than 7 days) or recently (between 7 and 30 days).
  • 3\. Third degree of atrial \- ventricle blockade.
  • 4\. Sing of Cardiac failure.
  • 5\. Preoperative use of inotropic drugs or mechanical support.
  • 6\. Obstructive lung diseases.
  • 7\. Patients with Coagulations disorders.
  • 8\. Patients with diagnosis of any diseases resulting in decrease of gastric empty, as Diabetes, peptic ulcer, pylorus stenosis or gastric tumor.

Outcomes

Primary Outcomes

Not specified

Similar Trials